Neurology practices manage some of the most medically complex patients in outpatient medicine. MS. Epilepsy. Parkinson's. Chronic migraine. ALS. The clinical work is demanding. The documentation is extensive. And the revenue cycle — built on top of that clinical complexity — is among the most technically difficult in all of healthcare.
And yet, the financial performance of many neurology practices doesn't reflect the work being done. Margins are softer than they should be. Collections lag behind appointment volume. Denied claims accumulate faster than they're worked.
The explanation isn't clinical. It's operational. Revenue is leaking through five quiet failures that compound slowly until someone looks closely enough to find them.
These are the five silent killers of neurology revenue.
1. The Code Graveyard
ICD-10 codes change annually. Some codes are revised, subdivided, or clarified. Others are simply deleted — rendered invalid, removed from the active code set, rejected automatically by every payer if they appear on a claim dated after the deletion effective date.
The Code Graveyard is what happens when practices don't keep their active billing logic, EHR defaults, and documentation templates updated with each year's code changes.
The most consequential example in 2026: ICD-10 code G35 (Multiple Sclerosis) was deleted effective October 1, 2025. Practices billing G35 on claims dated after that date received automatic invalid-code rejections — not medical necessity denials, not documentation disputes, just immediate rejections because the code no longer exists.
The code had been in use for years. Billers knew it by memory. EHR templates generated it automatically. Charge capture defaulted to it for MS patients. And then on October 1, 2025, it stopped working — and every practice that wasn't specifically watching for the deletion started generating a growing volume of rejected MS claims before the pattern became visible.
The Code Graveyard is a silent killer because it doesn't announce itself. A biller submitting claims in November 2025 using a code that worked perfectly in September 2025 may not realize the rejection rate has increased until month-end reporting reveals the pattern — and by then, weeks of MS claims have accumulated that need to be corrected and resubmitted.
The fix is upstream: automated ICD-10 validation that checks every claim against the current valid code set before submission and flags deleted or invalid codes at the point of charge capture.
Magical's AI employees run real-time ICD-10 validity checks on every claim — preventing code graveyard denials before they reach the payer.
2. The Study Count Trap
Nerve conduction study billing is one of the most financially significant and most consistently miscoded categories in neurology. The CPT tier — and therefore the reimbursement — depends on the number of studies performed. More studies, higher tier. Fewer studies, lower tier.
The Study Count Trap is the systematic billing of the wrong tier because the study count wasn't calculated precisely.
It happens in both directions.
Undercounting — when a biller applies a lower-tier code based on a rough assessment of the study report, when the actual documented study count supports a higher tier — is systematic revenue loss. The claim pays. It just pays less than it should, on every affected encounter, indefinitely.
Overcounting — when billers inflate study counts by including tests that don't qualify under the MAC's LCD rules as separately countable studies — generates audit flags and medical necessity denials. Most MAC LCDs limit the number of NCS studies to the minimum necessary to answer the clinical question. Billing above that limit without clear documentation that the additional studies were medically necessary puts the practice in an audit posture.
The Study Count Trap is a silent killer because the wrong-tier claim almost always pays. The undercounted claim gets processed at the lower rate, looks like a normal payment, and no one flags the difference. The overcounted claim may also pay initially — until the MAC's utilization review identifies a pattern and triggers a retrospective audit.
3. The Drug Unit Black Hole
For neurology practices administering Botox (onabotulinumtoxinA) and other botulinum toxin products therapeutically, chemodenervation billing has a layer of complexity that swallows revenue without generating any obvious signal: the drug unit calculation and waste billing.
Each botulinum toxin product bills at different units: Botox and Xeomin per single unit, Dysport per 5 units, Myobloc per 100 units. A single digit error in the unit count — submitting 15 units instead of 155 for a chronic migraine Botox session — represents a fraction of the legitimate drug reimbursement.
Both the amount administered and the drug wasted should be billed. If a 200-unit vial is mixed to administer 155 units, the 45 units wasted are also billable. Starting March 2026, Modifiers JW and JZ must be applied to document whether wastage occurred or whether the full vial was used. Practices that don't bill drug wastage are systematically leaving money on every partial-vial encounter.
And then there's the procedure code layer. CPT 64615, the migraine chemodenervation code, cannot be billed alongside 64612 or 64616. Doing so constitutes unbundling and generates a denial. For practices treating multiple anatomical regions in the same session — migraine and neck dystonia, for example — the correct procedure code combination requires careful anatomical selection.
The Drug Unit Black Hole is a silent killer because the claims keep getting submitted, some get paid, and the systematic underbilling on units and wastage never shows up as a denial. Revenue just comes in lower than it should, every injection cycle, indefinitely.
4. The LCD Invisibility Gap
Every Medicare Administrative Contractor maintains Local Coverage Determinations for neurology's highest-volume diagnostic procedures: EEG, EMG, nerve conduction studies, and select therapeutic procedures. These LCDs specify covered indications, documentation requirements, and utilization limits — and they are the actual rules that determine whether Medicare will pay.
The LCD Invisibility Gap is the practice of billing neurology diagnostic procedures without checking whether the documentation meets the specific MAC's coverage criteria.
The gap manifests predictably:
EEG submitted with a diagnosis of "headache" or "dizziness" when the MAC's LCD requires a specific neurological indication to justify the monitoring duration
NCS studies performed bilaterally when only unilateral symptoms are documented — bilateral testing requires documented bilateral symptoms
Long-term EEG monitoring submitted without documentation of why shorter study wasn't sufficient
EMG performed on extremities where symptoms aren't documented, generating denials when MAC utilization review identifies the mismatch
LCD coverage criteria for nerve conduction studies, EEGs, and EMGs are regularly updated by Medicare and commercial payers. A coverage criterion that applied six months ago may have been revised. A practice billing the same way it did last year on the same diagnostic procedure is potentially operating against outdated rules without knowing it.
The LCD Invisibility Gap is a silent killer because the denials it generates don't look structural — they look like individual medical necessity disputes. Each denial gets worked individually. The underlying pattern — that a specific diagnostic category is systematically failing LCD documentation requirements — never gets identified as a systemic issue.
5. Tele-Neurology Revenue Erosion
Telehealth has become a permanent and significant part of neurology practice. For chronic disease management of epilepsy, MS, Parkinson's, and migraine — conditions requiring regular monitoring but not physical examination — virtual visits are both clinically appropriate and patient-preferred.
But the billing errors that accumulate across tele-neurology encounters are persistently generating revenue erosion that practices rarely measure specifically.
The most financially significant:
The in-person misclassification — a telehealth visit processed without Modifier 95 is treated by the payer as an in-person visit. In some settings, this results in payment at a lower rate. In others, it results in a denial when the billing address doesn't match the patient's actual location. Either way, the revenue doesn't reflect the service delivered.
The RPM management time gap — RPM management codes (98980, 98981) require documented time of at least 20 minutes per month. Practices managing large RPM populations where time documentation is inconsistent are billing these codes on encounters where the required time isn't documented — generating denials that look like individual claim errors but represent a systematic time-documentation failure.
The new code capture gap — CPT 99470 (new for 2026) allows billing for 10-minute RPM management interactions for patients who don't reach the 20-minute threshold. Practices that haven't implemented this code are leaving remote monitoring revenue uncaptured on patients they're already actively managing.
Tele-neurology revenue erosion is a silent killer because each individual error looks like a routine billing adjustment. The claim processes at something. Nobody sees the gap between what the visit was worth and what was collected.
The Architecture of the Five
Look at these five killers together and the structure becomes clear.
The Code Graveyard and the LCD Invisibility Gap are knowledge failures — revenue lost because billing execution is based on rules that have changed without the practice's knowledge.
The Study Count Trap and the Drug Unit Black Hole are precision failures — revenue lost because the calculation required to bill correctly wasn't performed accurately.
Tele-Neurology Revenue Erosion is a model failure — revenue lost because a growing service line is being billed with an incomplete workflow.
All five share one characteristic: they pay at something. The claim isn't rejected entirely. Revenue just comes in lower than it should, at scale, across thousands of encounters, until someone builds the systems to catch the gap.
The Fix Requires Systematic Execution
Every one of these killers is solvable. Not through better training, more experienced billers, or harder manual review — but through systematic, automated execution that enforces the right billing logic at every claim, every encounter, every day.
ICD-10 validation that catches deleted codes before submission. Study count calculation that derives the correct NCS tier from clinical data. Drug unit validation that catches wastage billing gaps. LCD compliance checks that flag documentation mismatches before claims go out. Tele-neurology modifier validation on every virtual encounter.
Magical's agentic AI employees are built to run exactly this kind of systematic, claim-level execution — protecting neurology revenue from the silent failures that manual processes miss every day.
Want to see which silent killers are hitting your practice hardest? Book a demo to walk through a workflow assessment specific to your neurology practice.